Molecular and kinetic comparison of the novel extended-spectrum β-lactamases CTX-M-25 and CTX-M-26

被引:42
作者
Munday, CJ
Boyd, DA
Brenwald, N
Miller, M
Andrews, JA
Wise, R
Mulvey, MR
Hawkey, PA
机构
[1] Univ Birmingham, Sch Med, Div Immun & Infect, Antimicrobial Res Grp, Birmingham B15 2TT, W Midlands, England
[2] City Hosp, Dept Microbiol, Birmingham, W Midlands, England
[3] Hlth Canada, Natl Microbiol Lab, Nosocom Infect, Winnipeg, MB, Canada
[4] SMBD Jewish Gen Hosp, Montreal, PQ, Canada
关键词
D O I
10.1128/AAC.48.12.4829-4834.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CTX-M-25 is a novel extended-spectrum P-lactamase isolated from a single Canadian Escherichia coli isolate. Susceptibility testing demonstrated that this enzyme confers resistance to both cefotaxime and ceftazidime, but the level of resistance was reduced with the addition of P-lactamase inhibitors. The bla(CTX-M-25) gene was detected on a 111-kb plasmid. It is a member of the CTX-M-8 group and has the closest amino acid identity (99%; three amino acid substitutions) with CTX-M-26. The bla(CTX-M-26) gene was detected on a 100-kb plasmid isolated from a Klebsiella pneumoniae strain from the United Kingdom, and plasmid profiling revealed that it showed some homology to the bla(CTX-M-25)-harboring plasmid. Both CTX-M genes were located downstream of ISEcp1, although the copy upstream of bla(CTX-M-25) was disrupted by IS50-A. Comparative kinetic studies of recombinant CTX-M-25 and CTX-M-26 enzymes showed that CTX-M-25 has a higher level of ceftazidime hydrolysis (k(cat) values, 33 and 0.005 s(-1) for CTX-M-25 and CTX-M-26, respectively).
引用
收藏
页码:4829 / 4834
页数:6
相关论文
共 32 条
  • [1] CTX-M extended-spectrum β-lactamase arrives in the UK
    Alobwede, I
    M'Zali, FH
    Livermore, DM
    Heritage, J
    Todd, N
    Hawkey, PM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) : 470 - 471A
  • [2] A STANDARD NUMBERING SCHEME FOR THE CLASS-A BETA-LACTAMASES
    AMBLER, RP
    COULSON, AFW
    FRERE, JM
    GHUYSEN, JM
    JORIS, B
    FORSMAN, M
    LEVESQUE, RC
    TIRABY, G
    WALEY, SG
    [J]. BIOCHEMICAL JOURNAL, 1991, 276 : 269 - 270
  • [3] Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum β-lactamase CTX-M-9
    Aumeran, C
    Chanal, C
    Labia, R
    Sirot, D
    Sirot, J
    Bonnet, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) : 2958 - 2961
  • [4] Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland
    Baraniak, A
    Fiett, J
    Hryniewicz, W
    Nordmann, P
    Gniadkowski, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) : 393 - 396
  • [5] SINGLE AMINO-ACID SUBSTITUTION BETWEEN SHV-1 BETA-LACTAMASE AND CEFOTAXIME-HYDROLYZING SHV-2 ENZYME
    BARTHELEMY, M
    PEDUZZI, J
    BENYAGHLANE, H
    LABIA, R
    [J]. FEBS LETTERS, 1988, 231 (01): : 217 - 220
  • [6] INVERTED REPEATS OF TN5 ARE TRANSPOSABLE ELEMENTS
    BERG, DE
    JOHNSRUD, L
    MCDIVITT, L
    RAMABHADRAN, R
    HIRSCHEL, BJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (08): : 2632 - 2635
  • [7] On bridging the gap
    Bonner, LT
    [J]. ACADEMIC PSYCHIATRY, 2003, 27 (01) : 29 - 30
  • [8] A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil
    Bonnet, R
    Sampaio, JLM
    Labia, R
    De Champs, C
    Sirot, D
    Chanal, C
    Sirot, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) : 1936 - 1942
  • [9] Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly
    Bonnet, R
    Dutour, C
    Sampaio, JLM
    Chanal, C
    Sirot, D
    Labia, R
    De Champs, C
    Sirot, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) : 2269 - 2275
  • [10] An outbreak of a CTX-M-type β-lactamase-producing Klebsiella pneumoniae:: the importance of using cefpodoxime to detect extended-spectrum β-lactamases
    Brenwald, NP
    Jevons, G
    Andrews, JM
    Xiong, JH
    Hawkey, PM
    Wise, R
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) : 195 - U24